. . . . " Heparin" . "Pomoc\u00ED ACT stanovit procento v\u00FDskytu heparinov\u00E9 rezistence u operovan\u00FDch v mimot\u011Bln\u00EDm ob\u011Bhu. Vy\u0161et\u0159en\u00EDm hladiny antitrombinu III zjistit skute\u010Dn\u00FD vliv na heparinovou rezistenci u pacient\u016F operovan\u00FDch v mimot\u011Bln\u00EDm ob\u011Bhu. Zjistit vliv p\u0159edopera\u010Dn\u00EDho pod\u00E1v\u00E1n\u00ED heparinu na v\u00FDskyt heparinov\u00E9 rezistence. Stanovit d\u00E1vkov\u00E1n\u00ED heparinu a t\u00EDm omezit ne\u017E\u00E1douc\u00ED \u00FA\u010Dinky a poopera\u010Dn\u00ED komplikace." . " Extra-corporeal Circulation" . . . "2008-03-05+01:00"^^ . "2010-04-06+02:00"^^ . . "Byla zji\u0161t\u011Bna heparinov\u00E1 rezistence u 32,5 % pacient\u016F. Hladina antitrombinu III ? 60 % v plasm\u011B, po\u010Det desti\u010Dek 300 000/\u00B5l, p\u0159edopera\u010Dn\u00ED pod\u00E1n\u00ED heparinu a v\u011Bk ? 65 let maj\u00ED statisticky v\u00FDznamn\u00FD vliv na vznik heparinov\u00E9 rezistence."@cs . . "Following occurrence heparin resistance near population ill before operation heart in extra-corporeal circulation"@en . . . "2008-12-31+01:00"^^ . . "Heprin resistance; Antitrombin III; Extra-corporeal Circulation; Heparin; Protamin; Operation heart"@en . "1"^^ . " Protamin" . . "The heparin resistance was found at 32,5% of patients.The antithrombin III plasma level ? 60 %, platelets number ? 300 000/ \u00B5l, pre-operation application of heparin and age ?65 years are statistically significant factors of heparin resistance."@en . "http://www.isvav.cz/projectDetail.do?rowId=1A8590"^^ . "0"^^ . "2"^^ . "2"^^ . "0"^^ . . . . "Sledov\u00E1n\u00ED v\u00FDskytu heparinov\u00E9 rezistence u populace nemocn\u00FDch p\u0159ed operac\u00ED srdce v mimot\u011Bln\u00EDm ob\u011Bhu" . . . "Heprin resistance" . "By means of ACT, to establish the percentage of incidence of heparin resistance in patients operated in the extracorporeal circulation. By means of examination of antithrombin III level, to find out the real influence on heparin resistance in patients operated in the extracorporeal circulation. To find out the influence of pre-operational application of heparin on the incidence of heparin resistance. To establish the dosage of heparin, and thus to reduce the undesirable effects and post-operational complications."@en . "2005-08-01+02:00"^^ . . " Antitrombin III" . "1A8590" . .